Cargando…
Are mast cells instrumental for fibrotic diseases?
Idiopathic pulmonary fibrosis (IPF) is a fatal lung disorder of unknown etiology characterized by accumulation of lung fibroblasts and extracellular matrix deposition, ultimately leading to compromised tissue architecture and lung function capacity. IPF has a heterogeneous clinical course; however t...
Autores principales: | Overed-Sayer, Catherine, Rapley, Laura, Mustelin, Tomas, Clarke, Deborah L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896884/ https://www.ncbi.nlm.nih.gov/pubmed/24478701 http://dx.doi.org/10.3389/fphar.2013.00174 |
Ejemplares similares
-
Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects
por: Overed-Sayer, Catherine, et al.
Publicado: (2020) -
Modeling fibrotic alveolar transitional cells with pluripotent stem cell-derived alveolar organoids
por: Ptasinski, Victoria, et al.
Publicado: (2023) -
Genetic architecture of human fibrotic diseases: disease risk and disease progression
por: Gardet, Agnès, et al.
Publicado: (2013) -
Novel Anti-fibrotic Therapies
por: McVicker, Benita L., et al.
Publicado: (2017) -
A Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease
por: Fang, Lu, et al.
Publicado: (2017)